These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34055971)

  • 21. Development and validation of nomogram combining serum biomarker for predicting survival in patients with resected rectal cancer.
    Fan S; Li T; Zhou P; Peng Q; Zhu Y
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma.
    He Y; Liu H; Wang S; Chen Y
    PLoS One; 2019; 14(9):e0223275. PubMed ID: 31560723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic nomogram for predicting survival in patients with high grade endometrial stromal sarcoma: a Surveillance Epidemiology, and End Results database analysis.
    Wu J; Zhang H; Li L; Hu M; Chen L; Wu S; Xu B; Song Q
    Int J Gynecol Cancer; 2020 Oct; 30(10):1520-1527. PubMed ID: 32839227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nomogram for predicting the overall survival of patients with inflammatory breast cancer: A SEER-based study.
    Pan X; Yang W; Chen Y; Tong L; Li C; Li H
    Breast; 2019 Oct; 47():56-61. PubMed ID: 31351202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
    Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
    J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nomograms and risk classification systems predicting overall and cancer-specific survival in primary malignant cardiac tumor.
    Guan T; Li Y; Qiu Z; Zhang Y; Lin W; Lai Y; Wang K; Shen Y; Du L; Liu C
    J Card Surg; 2019 Dec; 34(12):1540-1549. PubMed ID: 31794125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Factors for Survival in Patients with Malignant Giant Cell Tumor of Bone: A Risk Nomogram Analysis Based on the Population.
    Zhu X; Huang R; Hu P; Yan P; Zhai S; Zhang J; Zhuang J; Yin H; Meng T; Yang D; Huang Z
    Med Sci Monit; 2021 Feb; 27():e929154. PubMed ID: 33594036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Clinical Model of Bone Angiosarcoma Patients: A Population-based Analysis of Epidemiology, Prognosis, and Treatment.
    Wang B; Chen LJ; Wang XY
    Orthop Surg; 2020 Dec; 12(6):1652-1662. PubMed ID: 32914587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment and Verification of a Nomogram for Predicting Survival in Patients with Small Intestinal Gastrointestinal Stromal Tumors.
    Lu G; Li J; Wu L; Shi Y; Zhang X; Xia Y; Li L
    Dig Dis; 2022; 40(1):50-61. PubMed ID: 33752202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
    Bongers MER; Karhade AV; Setola E; Gambarotti M; Groot OQ; Erdoğan KE; Picci P; Donati DM; Schwab JH; Palmerini E
    Clin Orthop Relat Res; 2020 Oct; 478(10):2300-2308. PubMed ID: 32433107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and external validation of nomograms to predict sarcoma-specific death and disease progression after surgical resection of localized high-grade conventional primary central chondrosarcoma and dedifferentiated chondrosarcoma.
    Tsuda Y; Tsoi K; Stevenson JD; Laitinen M; Ferguson PC; Wunder JS; Griffin AM; van de Sande MAJ; van Praag V; Leithner A; Fujiwara T; Yasunaga H; Matsui H; Parry MC; Jeys LM
    Bone Joint J; 2020 Dec; 102-B(12):1752-1759. PubMed ID: 33249892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Nomogram to Predict Individual Survival of Patients with Liver-Limited Metastases from Gastroenteropancreatic Neuroendocrine Neoplasms: A US Population-Based Cohort Analysis and Chinese Multicenter Cohort Validation Study.
    Xu G; Xiao Y; Hu H; Jin B; Wu X; Wan X; Zheng Y; Xu H; Lu X; Sang X; Ge P; Mao Y; Cai J; Zhao H; Du S
    Neuroendocrinology; 2022; 112(3):263-275. PubMed ID: 33902058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nomograms for predicting cancer-specific and overall survival in patients with invasive extramammary Paget's disease.
    Gao X; Zhong X; Chen HN; Singh D; Yang L; Huang LB; Wang C; Zhou ZG
    Future Oncol; 2021 Jul; 17(21):2785-2801. PubMed ID: 33988031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Nomogram and a Risk Classification System Predicting the Cancer-Specific Survival of Patients With Initially-Diagnosed Osseous Spinal and Pelvic Tumors.
    Zhou Q; Li AB; Lin ZQ; Zhang HZ
    Spine (Phila Pa 1976); 2020 Jun; 45(12):E713-E720. PubMed ID: 32039945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk Factors, Prognostic Factors, and Nomograms for Distant Metastasis in Patients With Newly Diagnosed Osteosarcoma: A Population-Based Study.
    Chen B; Zeng Y; Liu B; Lu G; Xiang Z; Chen J; Yu Y; Zuo Z; Lin Y; Ma J
    Front Endocrinol (Lausanne); 2021; 12():672024. PubMed ID: 34393996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
    Shi X; Xu L; Ma B; Wang S
    Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
    Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
    Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.
    Xu XL; Cheng H; Tang MS; Zhang HL; Wu RY; Yu Y; Li X; Wang XM; Mai J; Yang CL; Jiao L; Li ZL; Zhong ZM; Deng R; Li JD; Zhu XF
    Oncotarget; 2017 Jan; 8(5):8120-8130. PubMed ID: 28042955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction and validation of prognostic nomogram for metaplastic breast cancer.
    Li Y; Chen D; Xuan H; Dragomir MP; Calin GA; Meng X; Chen M; Jin H
    Bosn J Basic Med Sci; 2022 Feb; 22(1):131-139. PubMed ID: 34247567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nomograms-based prediction of overall and cancer-specific survivals for patients with chromophobe renal cell carcinoma.
    Chen C; Geng X; Liang R; Zhang D; Sun M; Zhang G; Hou J
    Exp Biol Med (Maywood); 2021 Mar; 246(6):729-739. PubMed ID: 33302735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.